Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study

Mostrar otras versiones (1)

BACKGROUND AND OBJECTIVE: To assess whether methylcobalamin and alpha lipoic acid (ALA) added to pregabalin provide additional benefit compared to pregabalin alone in type 2 diabetes mellitus associated peripheral neuropathy. SETTING AND DESIGN: An open label, randomized, controlled parallel-group p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasudevan, D., Naik, Manoj M., Mukaddam, Qayum I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992764/
https://www.ncbi.nlm.nih.gov/pubmed/24753654
http://dx.doi.org/10.4103/0972-2327.128535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992764/
https://www.ncbi.nlm.nih.gov/pubmed/24753654
http://dx.doi.org/10.4103/0972-2327.128535

Ejemplares similares